Efficacy of dual vaccination of pandemic H1N1 2009 influenza and seasonal influenza on institutionalized elderly: A one-year prospective cohort study

Vaccine

Volumn 29, Issue 44, 2011, Pages 7773-7778

  Chan, T C ^a,b   Hung, I F N ^b   Luk, J K H ^a   Shea, Y F ^a,b   Chan, F H W ^a   Woo, P C Y ^b   Chu, L W ^b  

^a Fung Yiu King Hospital   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Efficacy; Hospitalization; Influenza A (H1N1) 2009; Institutionalized elderly; Mortality; Vaccination

Indexed keywords

INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FEVER; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INFLUENZA VACCINATION; INSTITUTIONALIZATION; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; NURSING HOME; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEASONAL INFLUENZA; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HONG KONG; HOSPITALIZATION; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; INSTITUTIONALIZATION; MALE; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VACCINATION;

EID: 80053593181     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.07.112     Document Type: Article

References (33)

1. World Health Organization. Influenza (H1N1) - update 95 (cited 10 September 2010). Available from http://www.who.int/csr/don/2009_12_30/en/index.html.
2. Swine and Seasonal Flu Monitor. Center for Health Protection. Available http://www.chp.gov.hk/en/view_content/5473.html.
3. Wu J.T., Ma E.S.K., Lee C.K., Chu D.K., Ho P.L., Shen A.L., et al. The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong. Clin Infect Dis 2010, 51:1184-1191.
4. Tam N.V. Journal of epidemiology of influenza 1998, Blackwell Science, Oxford.
5. Cheng V.C. The prevention of nosocomial transmission of swine origin pandemic influenza virus by infection control bundle. J Hosp Infect 2010, 74:271-277.
6. Zhu F.C., Wang H., Fang H.H., Yang J.G., Lin X.J., Liang X.F., et al. A novel influenza A (H1N1) 2009 vaccine in various age group. N Engl J Med 2009, 361:2414-2423.
7. Clark T.W., Pareek M., Hoschler K., Dillon H., Nicholson K.G., Groth N., et al. Trial of 2009 influenza A (H1N1) monovalent MF-59 adjuvanted vaccine. N Engl J Med 2009, 361:2424-2435.
8. Greenberg M.E., Lai M.H., Hartel G.F., Wichems C.H., Gittleson C., Bennet J., et al. Response to a monovalent 2009 influenza A (H1N1) vaccine. N Engl J Med 2009, 361:2405-2413.
9. Liang X.F., Wang X.Q., Wang J.Z., Fang H.H., Wu J., Zhu F.C., et al. Safety and immunogenicity of pandemic influenza A vaccine in China: a multi-centre, double blind, randomized, placebo controlled trial. Lancet 2010, 375:56-66.
10. Hospital Authority annual report 2009.
11. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R., et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383.
12. Deyo R.A., Cherkin D.C., Ciol M.A. Adapting a clinical comorbidity index for use with ICD-9-CM administrative database. J Clin Epidemiol 1992, 45:613-619.
13. de Groot V., Beckerman H., Lankhorst G.J., Bouter L.M., et al. How to measure comorbidity: a critical review of available methods. J Clin Epidemiol 2003, 56:221-229.
14. Schneeweiss S., Maclure M. Use of comorbidity scores for control of confounding in studies using administrative databases. Int J Epidemiol 2000, 29:891-898.
15. Mahoney F., Barthel D. Functional evaluation: the Barthel Index. Md State Med J 1965, 14:61-65.
16. Torres Moreno B., Fernandez Duque O. Barthel and Charlson indexes for the prognosis of mortality and institutionalization in hospitalized geriatric patients. Rev Esp Geriatr Gerontol 2010, 45:111-116.
17. Noble G. Epidemiological and clinical aspects of influenza 1982, CRC Press, Boca Raton.
18. Chor J.S., Ngai K.L., Goggins W.B., Wong M.C., Wong S.Y., Lee N., et al. Willingness of Hong Kong healthcare workers to accept pre-pandemic influenza vaccination at different WHO alert levels: two questionnaire surveys. BMJ 2009, 339:b3391.
19. Lau J.T.F., Yeung N.C.Y. Acceptability of A/H1N1 vaccination during pandemic phase of influenza A/H1N1 in Hong Kong: population based cross sectional survey. BMJ 2009, 339:b4164.
20. Hui D.S., Woo J., Hui E. Influenza like illness in residential care homes: a study of the incidence, etiological agents, and natural history and health resource utilization. Thorax 2008, 63:690-697.
21. Smeeth L., Thoma S.L., Hall A.J., Hubbard R., Farrington P., Vallance P., et al. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 2004, 351:2611-2618.
22. Corrales-Medina V.F., Madjid M., Musher D.M. Role of acute infection in triggering acute coronary syndromes. Lancet Infect Dis 2010, 10:83-92.
23. Woo P.C., Tung E.T., Chan K.H., Lau C.C., Lau S.K., Yuen K.Y., et al. Cytokines profiles induced by the novel swine-origin influenza A/H1N1 virus: implication for treatment strategies. J Infect Dis 2010, 201:346-353.
24. Hung I.F., Leung A.Y., Chu D.W., Leung D., Cheung T., Chan C.K., et al. Prevention of acute myocardial infarction and stroke among elderly persons by dual pneumococcal and influenza vaccination: a prospective cohort study. Clin Infect Dis 2010, 51:1007-1010.
25. Govaert T.M., Thijs C.T., Masurel N., Sprenger M.J., Dinant G.J., Knottnerus J.A., et al. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA 1994, 272:1661-1665.
26. Allsup S., Haycox A., Regan M., Gosney M. Is influenza vaccination cost effective for healthy people between ages 65 and 74 years? A randomized controlled trial. Vaccine 2004, 23:639-645.
27. Jefferson T., Rivetti D., Rivetti A., Rudin M., Di Pietrantonj C., Demicheli V. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet 2005, 366:1165-1174.
28. Simonsen L., Taylor R.J., Viboud C., Miller M.A., Jackson L.A. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis 2007, 7:658-666.
29. Jackson L.A., Nelson J.C., Benson P., Neuzil K.M., Reid R.J., Psaty B.M., et al. Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. Int J Epidemiol 2006, 35:345-352.
30. Goodwin K., Viboud C., Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006, 24:1159-1169.
31. Kao T.M., Hsieh S.M., Kung H.C., Lee Y.C., Huang K.C., Huang L.M. Immune response of single dose vaccination against 2009 pandemic influenza A (H1N1) in the Taiwanese elderly. Vaccine 2010, 28:6159-6163.
32. Tang M., Woo J., Hui E., Chan F., Lee J., Sham A., et al. Utilization of emergency room and hospitalization by Chinese nursing home residents. A cross sectional study. J Am Med Dir Assoc 2010, 11:325-332.
33. Janjua N.Z., Skowronski D.M., Hottes T.S., Osei W., Adams E., Petric M., et al. Seasonal influenza vaccine and increased risk of pandemic A/H1N1-related illness: first detection of the association in British Columbia, Canada. Clin Infect Dis 2010, 51:1017-1027.